|
Primary and Secondary Stroke Prevention
Citations 51-60 of 77 total displayed.
|
Past content
(since Sep 1999):
|
- AHA Special Reports
Report of the American Heart Association Task Force on Strategic Research Direction: Executive Summary
- Robert Roberts, Robert O. Bonow, Joseph Loscalzo, and Lori Mosca
Circulation 2002;106:2630-2632, doi:10.1161/01.CIR.0000037747.50168.9C
[Full text]
- Surgery for Coronary Heart Disease
Brachial Gradient in Cardiac Surgical Patients
- Yvon Baribeau, Benjamin M. Westbrook, David C. Charlesworth, Michael J. Hearne, William A. Bradley, and Christopher T. Maloney
Circulation 2002;106:I-11-13I-, doi:10.1161/01.cir.0000032894.55215.32
[Abstract]
[Full text]
- Editorials
Reducing the Risk for Stroke in Patients With Myocardial Infarction: A Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Substudy
- Antonio M. Gotto, Jr and John A. Farmer
Circulation 2002;106:1595-1598, doi:10.1161/01.CIR.0000033310.73775.66
[Full text]
- Clinical Investigations and Reports
Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy
- David D. Waters, Gregory G. Schwartz, Anders G. Olsson, Andreas Zeiher, Michael F. Oliver, Peter Ganz, Michael Ezekowitz, Bernard R. Chaitman, Sally J. Leslie, Theresa Stern for the MIRACL Study Investigators
Circulation 2002;106:1690-1695; published online before print as doi:10.1161/01.CIR.0000031568.40630.1C
[Abstract]
[Full text]
- Articles
Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction. A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy
- David D. Waters, Gregory G. Schwartz, Anders G. Olsson, Andreas Zeiher, Michael F. Oliver, Peter Ganz, Michael Ezekowitz, Bernard R. Chaitman, Sally J. Leslie, Theresa Stern for the MIRACL Study Investigators
Circulation published September 3, 2002, doi:10.1161/01.CIR.0000031568.40630.1C
[Abstract]
- AHA Scientific Statements
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases
- Thomas A. Pearson, Steven N. Blair, Stephen R. Daniels, Robert H. Eckel, Joan M. Fair, Stephen P. Fortmann, Barry A. Franklin, Larry B. Goldstein, Philip Greenland, Scott M. Grundy, Yuling Hong, Nancy Houston Miller, Ronald M. Lauer, Ira S. Ockene, Ralph L. Sacco, James F. Sallis, Jr, Sidney C. Smith, Jr, Neil J. Stone, and Kathryn A. Taubert
Circulation 2002;106:388-391, doi:10.1161/01.CIR.0000020190.45892.75
[Full text]
- Clinical Investigations and Reports
Meta-Analysis of Wine and Beer Consumption in Relation to Vascular Risk
- Augusto Di Castelnuovo, Serenella Rotondo, Licia Iacoviello, Maria Benedetta Donati, and Giovanni de Gaetano
Circulation 2002;105:2836-2844; published online before print as doi:10.1161/01.CIR.0000018653.19696.01
[Abstract]
[Full text]
- Clinical Investigations and Reports
Transcatheter Closure of Interatrial Communications for Secondary Prevention of Paradoxical Embolism: Single-Center Experience
- Leonhard Bruch, Anne Parsi, Marc Oliver Grad, Sascha Rux, Telse Burmeister, Heike Krebs, and Franz Xaver Kleber
Circulation 2002;105:2845-2848, doi:10.1161/01.CIR.0000019069.32964.0E
[Abstract]
[Full text]
- Current Perspectives
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease
- Robert H. Eckel, Winifred W. Barouch, and Abby G. Ershow
Circulation 2002;105:2923-2928, doi:10.1161/01.CIR.0000017823.53114.4C
[Full text]
- Editorials
Inflammatory Biomarkers, Statins, and the Risk of Stroke: Cracking a Clinical Conundrum
- Paul M. Ridker
Circulation 2002;105:2583-2585, doi:10.1161/01.CIR.0000017822.82512.62
[Full text]
|
|
